Omnaris Articles
Nycomed debuts Omnaris nasal spray in the UAE
14 March 2012
Sepracor's 1st-qtr revenues jump 3%
5 May 2009
Nycomed licenses US rights to ciclesonide drugs to Sepracor in deal worth up to $430M
4 February 2008
FDA clears Omnaris for pediatric allergic rhinitis
30 October 2006
Showing 1-5 of 5 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
